DATA AVAILABILITY STATEMENT
The data that support the findings of this study are available from the
corresponding author upon reasonable request.
REFERENCES
[1] Harden ME, Munger K. Human papillomavirus molecular biology.
MUTAT RES-REV MUTAT. 2017;772:3-12.
[2] Petca A, Borislavschi A, Zvanca ME, et al. Non-sexual HPV
transmission and role of vaccination for a better future. EXP THER MED.
2020;20(6):186.
[3] Soheili M, Keyvani, Soheili M, et al.
Human
papilloma virus: A review study of
epidemiology,carcinogenesis,diagnostic methods, and treatment of all
HPV-related cancers. Med J Islam Repub Iran. 2021;35:65.
[4] Shapiro SB, Wissing MD, Khosrow-Khavar F, et al. Male
Circumcision and Genital Human Papillomavirus (HPV) Infection in Males
and Their Female Sexual Partners: Findings from the HPV Infection and
Transmission Among Couples Through Heterosexual Activity (HITCH) Cohort
Study. J INFECT DIS. 2022;226(7):1184-1194.
[5] de Martel C, Georges D, Bray F, et al. Global burden of cancer
attributable to infections in 2018: a worldwide incidence analysis.
Lancet Glob Health. 2020;8(2):180-190.
[6] Forman D, de Martel C, Lacey C J, et al. Global Burden of Human
Papillomavirus and Related Diseases. Vaccine. 2012;30 Suppl 5:F12–23.
[7] Hartwig S, Syrjänen S, Dominiak-Felden G, et al. Estimation of
the epidemiological burden of human papillomavirus-related cancers and
non-malignant diseases in men in Europe: A review. BMC Cancer.
2012;12:30.
[8] Tisi G, Salinaro F, Apostoli P, et al. HPV vaccination
acceptability in young boys. Annali dell’Istituto Superiore di Sanità.
2013;49(3):286–291.
[9] Sammarco ML, Ucciferri C, Tamburro M, et al. High prevalence of
human papillomavirus type 58 in HIV infected men who have sex with men:
A preliminary report in Central Italy. J Med Virol. 2016;88(5):911-914.
[10] Handisurya A, Rieger A, Bankier A, et al. Human papillomavirus
type 26 infection causing multiple invasive squamous cell carcinomas of
the fingernails in an AIDS patient under highly active antiretroviral
therapy. BRIT J DERMATOL. 2007;157(4):788-794.
[11] Olesen TB, Sand FL, Rasmussen CL, et al. Prevalence of human
papillomavirus DNA and p16INK4a in penile cancer and penile
intraepithelial neoplasia: a systematic review and meta-analysis. LANCET
ONCOL. 2019;20(1):145-158.
[12] Laura Elst, Maarten Albersen. HPV Vaccination: Does It Have a
Role in Preventing Penile Cancer and Other Preneoplastic Lesions? SEMIN
ONCOL NURS. 2022;38(3):151284.
[13] Schneede P. Human papillomavirus disease burden in men: HPV
prevention is a man’s business. UROLOGE. 2018;57(12):1452-1456.
[14]
MCBRIDE A A. Human Papillomaviruses: diversity, infection and host
interactions. Nature Rev Microbiol. 2022;20:95-108.
[15] Thomas A, Necchi A, Muneer A, et al. Penile cancer. Nat Rev Dis
Primers. 2021;7(1):11.
[16] Spiess PE, Dhillon J, Baumgarten AS, et al. Pathophysiological
basis of human papillomavirus in penile cancer: Key to prevention and
delivery of more effective therapies. CA Cancer J Clin.
2016;66(6):481–495.
[17] World Health Organization. Human papillomaviruses; World Health
Organization: Lyon, 262 France, (2006).
[18] DOORBAR J. Molecular biology of human papillomavirus infection
and cervical cancer. Clin Sci (Lond). 2006;110(5):525-541.
[19] WU X, WANG S, LI M, et al. Conditional reprogramming:next
generation cell culture. Acta Pharm Sin B. 2020;10(8):1360-1381.
[20] Saunders-Wood T, Egawa N, Zheng K, et al. Role of E6 in
Maintaining the Basal Cell Reservoir during Productive
Papillomavirus Infection. J VIROL. 2022;96(5):e0118121.
[21] Stone KM, Karem KL, Sternberg MR, et al. Seroprevalence of
human papillomavirus type 16 infection in the United States. J INFECT
DIS. 2002;186(10):1396-1402.
[22] Peterson LM, Orr JA, Rogelberg SD, et al. Social-contextual
factors interact with masculinity to influence college men’s HPV
vaccination intentions: The role of descriptive norms, prototypes, and
physician gender. J BEHAV MED. 2022;45(6):825-840.
[23] Nemcova J, Riegert J, Cerna K, et al. Prevalence of oral and
anal human papillomavirus infection in Czech predominantly Human
immunodeficiency virus-positive men having sex with men - data from a
previously unreported population. Ondic, O; INT J STD AIDS.
2022;33(12):1054-1064.
[24] Skoulakis A, Fountas S, Mantzana-Peteinelli M, et al.
Prevalence of human papillomavirus and subtype distribution in male
partners of women with cervical intraepithelial neoplasia (CIN): A
systematic review. BMC Infect Dis. 2019;19(1):192.
[25] Lau JT, Wang Z, Lau M, et al. Perceptions of HPV, genital
warts, and penile/anal cancer and high-risk sexual behaviors among men
who have sex with men in Hong Kong. ARCH SEX BEHAV. 2014;43(4):789-800.
[26] Sudenga SL, Torres BN, Silva R, et al. Comparison of the
natural history of genital HPV infection among men by country: Brazil,
Mexico, and the United States. Cancer Epidem Biomar.
2017;26(7):1043-1052.
[27] MOREIRA ED, GIULIANO AR, PALEFSKY J, et al. Incidence,
clearance, and disease progression of genital human papillomavirus
infection in heterosexual men. J Infect Dis. 2014;210(2):192-199.
[28] Li X, Li M, Yang Y, et al. Anal HPV/HIV co-infection among men
who have sex with men: A cross-sectional survey from three cities in
China. Sci Rep. 2016;6:21368.
[29] Yin W G, Yang M, Peng L, et al. Male papillomavirus infection
and genotyping in the Qingyuan area. Virol J. 2020;17(1):155.
[30] Xin H, Li H, Li Z, et al. Genital HPV infection among
heterosexual and homosexual male attendees of sexually transmitted
diseases clinic in Beijing, China. Epidemiol Infect.
2017;145(13):2838-2847.
[31] Xiaoxiao Li, Fenfen Xiang, Zixi Chen, et al. Genital Human
Papillomavirus Prevalence and Genotyping Among Males in Putuo District
of Shanghai, China 2015-2019. CLINICAL RESEARCH. 2021;27: e932093.
[32] Shigehara K, Sasagawa T, Kawaguchi S, et al. Prevalence of
human papillomavirus infection in the urinary tract of men with
urethritis. Int J Urol. 2010;17(6):563-568.
[33] Hoai BN, Cao TN, Luong Thi LA, et al. Human papillomavirus
prevalence and genotype distribution in Vietnamese male patients between
2016 and 2020. J MED VIROL. 2022;94(6):2892-2896.
[34] Herrero R, Castle PE, Schiffman M, et al. Epidemiologic profile
of type-specific human papillomavirus infection and cervical neoplasia
in Guanacaste, Costa Rica. J Infect Dis. 2005;191(11):1796-1807.
[35] Finan RR, Chemaitelly H, Racoubian E, et al. Genetic diversity
of human papillomavirus (HPV) as specified by the detection method,
gender, and year of sampling: a retrospective cross-sectional study.
ARCH GYNECOL OBSTET. 2023;307(5):1469-1479.
[36] Bruni L, Diaz M, Castellsagué X, Ferrer E, et al. Cervical
human papillomavirus prevalence in 5 continents: meta-analysis of 1
million women with normal cytological findings. J Infect Dis.
2010;202(12):1789-1799.
[37] Goldstone SE, Giuliano AR, Palefsky JM, et al. Efficacy,
immunogenicity, and safety of a quadrivalent HPV vaccine in men: results
of an open-label, long-term extension of a randomised,
placebo-controlled, phase 3 trial. Lancet Infect Dis.
2022;22(3):413-425.
[38] da Costa Nunes JF, Pires S, Chade DC. Human papillomavirus
vaccination and prevention of intraepithelial neoplasia and penile
cancer: review article. Curr Opin Urol. 2020;30(2):208-212.
[39] Li-li Zheng, Shuang-feng Chen, Fei Yang, et al. High-risk HPV
prevalence and genotype distribution among women in Liaocheng, Shandong
Province, China from 2016 to 2022. Front Public Health. 2023;11:1145396.
[40] WHO. Human papillomavirus and related diseases report.
2021(2021-10-22) [2022-06-06]. https:// hpvcentre.net /statistics
/reports /X-WX.pdf.
[41] Laseron O, Oliffe JL, Krist J, et al. HPV vaccine and
college-age men: a scoping review. Am J Men’s Health. 2020;14
(6):1557988320973826.
Tables